Bone Marrow Transplantation News

ASH announced the 36 recipients of the society’s 2022 Scholar Awards.

Fox Chase Cancer Center announced two faculty appointments.

A woman from the United States is the third person to achieve sustained treatment-free HIV remission after undergoing a stem cell transplant, researchers announced.

The Fred Hutch/University of Washington Cancer Consortium has announced new leadership.

Although vaccines reduce the overall risk for COVID-19 regardless of immune status, patients with immune dysfunction are at a “substantial risk” for breakthrough infection versus those without, according to data.

The 2-year OS rate nearly doubled during the past 2 decades among patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who relapsed after allogeneic hematopoietic stem cell transplantation, according to study results.

Depletion of naive T cells from peripheral blood stem cell grafts resulted in very low incidence of severe acute and any graft-versus-host disease in three phase 2 clinical trials, according to a study in Journal of Clinical Oncology.

Individuals with acute myeloid leukemia in remission after hematopoietic stem cell transplantation reported ongoing symptoms and impacts in the post-transplant period, according to research presented at ASH Annual Meeting and Exposition.

The FDA approved abatacept in combination with a calcineurin inhibitor and methotrexate for prevention of acute graft versus host disease.

The American Society of Hematology will present this year’s ASH Outstanding Service Award to Peter Marks, MD, PhD.